Clinical trial
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
NCT00005035 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005035 |
|---|---|
| Title | Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer |
| Official title | A Phase II Study of Oxaliplatin in Patients With Advanced Carcinoma of the Head and Neck |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Start date | Dec 1, 1999 |
| Completion | Mar 1, 2004 |
| First posted | Mar 4, 2004 |
| Last update posted | Jan 31, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: